rotarix oral suspension (oral applicator)
glaxosmithkline pte ltd - human rotavirus, live, attenuated, rix 4414 strain - suspension - not less than 10⁶ ccid₅₀/dose (1.5 ml) - human rotavirus, live, attenuated, rix 4414 strain not less than 10⁶ ccid₅₀/dose (1.5 ml)
rotarix
glaxosmithkline pte ltd - human rotavirus, live, attenuated, rix 4414 strain - powder, for suspension - not less than 10⁶ ccid₅₀/dose (1.0 ml) - human rotavirus, live, attenuated, rix 4414 strain not less than 10⁶ ccid₅₀/dose (1.0 ml)
rotarix oral suspension (tube)
glaxosmithkline pte ltd - human rotavirus, live, attenuated, rix 4414 strain - suspension - not less than 10⁶ ccid₅₀/dose (1.5 ml) - human rotavirus, live, attenuated, rix 4414 strain not less than 10⁶ ccid₅₀/dose (1.5 ml)
rotarix suspension
glaxo smith kline (israel) ltd - live attenuated human rotavirus rix4414 strain - suspension - live attenuated human rotavirus rix4414 strain - rota virus, live attenuated - rota virus, live attenuated - rotarix is indicated for the active immunization of infants from the age of 6 weeks for prevention of gastro-enteritis due to rotavirus infection. in clinical trials, efficacy was demonstrated against gastro-enteritis due to rotavirus of types g1p[8], g2p[4], g3p[8], g4p[8] and g9p[8]. the use of rotarix should be based on official recommendations.
rotateq
merck sharp & dohme b.v. - rotavirus serotype g1, serotype g2, serotype g3, serotype g4, serotype p1 - immunization; rotavirus infections - vaccines, viral vaccines - rotateq is indicated for the active immunisation of infants from the age of six weeks to 32 weeks for prevention of gastroenteritis due to rotavirus infection.rotateq is to be used on the basis of official recommendations.
rotarix
glaxosmithkline biologicals s.a. - human rotavirus, live attenuated - immunization; rotavirus infections - vaccines - rotarix is indicated for the active immunisation of infants aged 6 to 24 weeks for prevention of gastroenteritis due to rotavirus infection.the use of rotarix should be based on official recommendation.
rotarix vaccine live oral suspension 1.5ml tube
glaxosmithkline uk ltd - human rotavirus rix4414 strain live attenuated - oral suspension
rotarix suspension oral
glaxosmithkline biologicals s.a. - human rotavirus vaccine live - suspension oral - not less than 10^6ccid^50/dose
rotateq solution oral
merck sharp & dohme b.v. waarderweg 39 - rotavirus type g1, rotavirus type g2, rotavirus type g3, rotavirus type g4, rotavirus type p1a - solution oral - not less than 2,2x10^6iu+ not less than 2,8x106iu+ not less than 2,2x10^6iu+ not less than 2x10^6iu+ not less than 2,3x10^6iu
rotateq solution oral
merck sharp & dohme b.v. waarderweg 39 - rotavirus type g1, rotavirus type g2, rotavirus type g3, rotavirus type g4, rotavirus type p1a - solution oral - not less than 2,2x10^6iu+ not less than 2,8x106iu+ not less than 2,2x10^6iu+ not less than 2x10^6iu+ not less than 2,3x10^6iu